Zecotek Photonics Receives US$1.5M Order for Patented LFS Scintillation Crystals

Zecotek Photonics Inc. (TSXV:ZMS,OTCPK:ZMSPF,FWB:W1I) received a US$1,500,000 order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from its strategic partner, Hamamatsu Photonics.

As quoted in the press release:

On July 16, 2013 Zecotek and Hamamatsu announced a strategic partnership to commercialize existing imaging technologies and to collaborate on the upgrade and manufacture of photo detectors, integrated detector modules and associated electronics and data acquisition modules for the imaging markets at large. Hamamatsu is the world’s leading supplier of optoelectronics components including photo multiplier tubes and photo-diodes used in positron emission tomography (PET) medical scanners, the European Organization for Nuclear Research (CERN) projects and other industrial and scientific applications.

Zecotek’s patented (US patent No. 7,132,060) LFS series of scintillation crystals are known for their high light yields and ultra-fast decay times which allow for faster and higher-resolution operation of medical and industrial imaging devices including PET medical scanners. Zecotek’s line of LFS crystals also cover a wide range of emission wavelengths which can be tailored to match the spectral sensitivity of various photo detectors including the solid-state MAPD photo detector arrays.

Zecotek Photonics Inc. Chairman, President, and CEO, Dr. A.F. Zerrouk, said:

Hamamatsu is actively marketing Zecotek’s patented LFS scintillation crystals. PET manufacturers are recognizing the cost/performance/IP advantages of using the LFS scintillation crystal. I am very pleased with the efforts of our strategic partner Hamamatsu. The LFS technology was well covered at the recent Nuclear Science Symposium and IEEE conference in Seoul, Korea and in front of thousands of Hamamatsu’s customers at the November Photon fair in Japan. Our joint imaging projects are well on their way.

Click here to read the Zecotek Photonics Inc. (TSXV:ZMS,OTCPK:ZMSPF,FWB:W1I) press release